• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPECTRANETICS STELLAREX 0.014 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPECTRANETICS STELLAREX 0.014 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER Back to Search Results
Model Number AA14SX035040150
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Occlusion (1984)
Event Date 10/25/2018
Event Type  Injury  
Manufacturer Narrative
The patient's ethnicity and race are unknown.This information was not available from the facility.The patient required revascularization of the target lesion.This is being reported as part of the clinical study.Cross reference mfr report numbers: 3009784280-2020-00318, 3009784280-2020-00319, 3009784280-2020-00320.Foreign- (b)(6) study name: (b)(6)- patient id: (b)(6).Pma number is not applicable.The device is a commercial product with a ce mark that was used as part of a clinical study.During the index procedure, the product worked as intended and the device was discarded, thus no product evaluation was performed.Per the ifu, occlusion is listed as a potential complications/ adverse events.
 
Event Description
Hold for ab 12.28 it was reported through a clinical database that during the index procedure on (b)(6) 2018, four stellarex catheters were used to treat the target lesion of the right proximal and distal posterior tibial.Approximately 2 days post index procedure, the patient experienced an occlusion.A successful revascularization of the target lesion was performed on (b)(6) 2018.The physician indicated this is possibly related to the study device and is related to the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLAREX 0.014 OTW DRUG-COATED ANGIOPLASTY BALLOON
Type of Device
DCB PTA CATHETER
Manufacturer (Section D)
SPECTRANETICS
6531 dumbarton circle
fremont CA 94555
Manufacturer (Section G)
SPECTRANETICS
6531 dumbarton circle
fremont CA 94555
Manufacturer Contact
diana melliza galvez
5055 brandin court
fremont, CA 94555
510933-791
MDR Report Key11066531
MDR Text Key224116951
Report Number3009784280-2020-00321
Device Sequence Number1
Product Code ONU
Combination Product (y/n)Y
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,study
Reporter Occupation Physician
Type of Report Initial
Report Date 12/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/26/2019
Device Model NumberAA14SX035040150
Device Catalogue NumberAA14SX035040150
Device Lot NumberFFL17E03A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age83 YR
Patient Weight83
-
-